Cellectar Biosciences (CLRB)
(Delayed Data from NSDQ)
$3.03 USD
+0.01 (0.33%)
Updated Apr 26, 2024 03:59 PM ET
After-Market: $3.03 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/2/24 |
---|---|
Current Quarter | -0.50 |
EPS Last Quarter | -0.66 |
Last EPS Surprise | -11.86% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.85 |
Next Year | -0.59 |
EPS (TTM) | -2.97 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | 54.56M |
# of Estimates | NA | NA | NA | 2 |
High Estimate | NA | NA | NA | 88.82M |
Low Estimate | NA | NA | NA | 20.30M |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.50 | -0.42 | -1.85 | -0.59 |
# of Estimates | 2 | 2 | 3 | 2 |
Most Recent Consensus | -0.53 | -0.40 | -1.64 | 0.13 |
High Estimate | -0.47 | -0.40 | -1.64 | 0.13 |
Low Estimate | -0.53 | -0.44 | -2.18 | -1.30 |
Year ago EPS | -0.76 | -0.73 | -3.15 | -1.85 |
Year over Year Growth Est. | 34.21% | 42.47% | 41.27% | 68.38% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 1 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 1 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.50 | -0.42 | -1.85 | -0.59 |
7 Days Ago | -0.50 | -0.42 | -1.85 | -0.59 |
30 Days Ago | -0.50 | -0.42 | -1.69 | -0.59 |
60 Days Ago | -0.53 | -0.44 | -2.23 | -0.46 |
90 Days Ago | -0.53 | -0.44 | -2.23 | -0.46 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.50 | -0.42 | -1.85 | -0.59 |
Zacks Consensus Estimate | -0.50 | -0.42 | -1.85 | -0.59 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.66 | -0.82 | -0.73 | -0.76 | NA |
Estimate | -0.59 | -0.44 | -0.69 | -0.75 | NA |
Difference | -0.07 | -0.38 | -0.04 | -0.01 | -0.13 |
Surprise | -11.86% | -86.36% | -5.80% | -1.33% | -26.34% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more